Evidence map›Paper›PMID 23392465›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2013

Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus.

M J McElrath, K Smythe, J Randolph-Habecker, K R Melton, T A Goodpaster, S M Hughes, M Mack, A Sato, G Diaz, G Steinbach and 9 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Sex Differences in HIV Infection.Current topics in microbiology and immunology · 2023
    Article
  10. Review
  11. Identification of CX3CR1iScience · 2022
    Article
  12. The Role of Inflammation in Anal Cancer.Diseases (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Curlin, M [corrected to Curlin, Marcel E]
5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

M J McElrathVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
K Smythe
J Randolph-Habecker
K R Melton
T A Goodpaster
S M Hughes
M Mack
A Sato
G Diaz
G Steinbach
R M Novak
Marcel E Curlin
M Curlin
J D Lord
J Maenza
A Duerr
N Frahm
Florian Hladik
NIAID HIV Vaccine Trials Network
Infectious Disease Research Institute · USFred Hutch Cancer Center · USUniversity of Washington · USUniversity Hospital Regensburg · DEUniversity of Illinois Chicago · USVirginia Mason Medical Center · US

Funding

LOC: HIV Vaccine Trials NetworkUM1AI068614 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Dan H. Barouch, Lawrence Corey · 2011 to 2026
$1175.6M
LC: HIV Vaccine Trials NetworkUM1AI068618 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Margaret Juliana McElrath · 2011 to 2026
$483.6M
HVTN Laboratory ProgramU01AI068618 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MCELRATH, MARGARET JULIANA · 2006 to 2010
$82.6M
Mechanisms of HIV-1 Transmission in the Genital Mucosa of WomenR01HD051455 · NICHD · UNIVERSITY OF WASHINGTON · PI HLADIK, FLORIAN · 2006 to 2008
$1.2M
NIAID NIH HHS U01 AI068618NIAID NIH HHS U01AI068618NIAID NIH HHS UM1 AI068614NIAID NIH HHS UM1 AI068618NICHD NIH HHS R01 HD051455NICHD NIH HHS R01HD51455
6 · The paper itself

Abstract

backgroundPrevention of rectal HIV transmission is a high-priority goal for vaccines and topical microbicides because a large fraction of HIV transmissions occurs rectally. Yet, little is known about the specific target-cell milieu in the human rectum other than inferences made from the colon.

methodsWe conducted a comprehensive comparative in situ fluorescence study of HIV target cells (CCR5-expressing T cells, macrophages, and putative dendritic cells) at 4 and 30 cm proximal of the anal canal in 29 healthy individuals, using computerized analysis of digitized combination stains.

resultsMost strikingly, we find that more than 3 times as many CD68 macrophages express the HIV coreceptor CCR5 in the rectum than in the colon (P = 0.0001), and as such rectal macrophages seem biologically closer to the HIV-susceptible CCR5 phenotype in the vagina than the mostly HIV-resistant CCR5 phenotype in the colon. Putative CD209 dendritic cells are generally enriched in the colon compared with the rectum (P = 0.0004), though their CCR5 expression levels are similar in both compartments. CD3 T-cell densities and CCR5 expression levels are comparable in the colon and rectum.

conclusionsOur study establishes the target-cell environment for HIV infection in the human distal gut and demonstrates in general terms that the colon and rectum are immunologically distinct anatomical compartments. Greater expression of CCR5 on rectal macrophages suggests that the most distal sections of the gut may be especially vulnerable to HIV infection. Our findings also emphasize that caution should be exercised when extrapolating data obtained from colon tissues to the rectum.

Indexed as

AdultAnal CanalAntigens, CDAntigens, Differentiation, MyelomonocyticCD3 ComplexCD68 MoleculeDendritic CellsGastrointestinal TractHIV-1HIV InfectionsHumansLymphocyte CountMacrophagesMaleMiddle AgedReceptors, CCR5Antigens, CDAntigens, Differentiation, MyelomonocyticCD3 ComplexCD68 antigen, humanCD68 MoleculeReceptors, CCR5

Identifiers

PMID23392465
PMCPMC3683090
OpenAlexW2064187617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.